Biomarin announces
December 30th, 2008Biomarin announces
BIOMARIN PHARMACEUTICAL INC.
10/15/08: BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell ... 10/07/08: BioMarin to Host Third Quarter 2008 Financial Results Conference Call ... (more...)
BioMarin Announces Second Quarter 2006 Financial Results
Strong Naglazyme Sales Lead to Improved Top- and Bottom-Line Guidance for 2006 Conference Call and Webcast to Be Held Today at 5:00 p.m. (more...)
BioMarin Announces Initiation Of Clinical Assessment Program For ...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced the initiation of the Morquio Clinical Assessment Program (MorCAP) for patients with the lysosomal storage disease ... (more...)
BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief ...
NOVATO, Calif., Nov. 21 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Dr. Emil Kakkis, its Chief Medical Officer will retire from the ... (more...)
BioMarin Announces Third Quarter 2008 Financial Results
Well-Positioned for Continued Long-Term Growth Conference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET) (more...)